SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905718-22-000607
Filing Date
2022-04-14
Accepted
2022-04-14 16:42:16
Documents
2
Group Members
COMMODORE CAPITAL MASTER LP

Document Format Files

Seq Description Document Type Size
1 VISTAGEN_13GAPR42022 vistagen_13gapr42022.htm SC 13G 56098
2 VISTAGEN JOINT FILING AGREEMENT ex-1vistajointfilingagmt.htm EX-1 7674
  Complete submission text file 0000905718-22-000607.txt   65399
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Subject) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-86249 | Film No.: 22827812
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 FIFTH AVE 12TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVE 12TH FLOOR NEW YORK NY 10153 917-970-1730
COMMODORE CAPITAL LP (Filed by) CIK: 0001831942 (see all company filings)

IRS No.: 832659606 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G